OncoNano Medicine's Series A Round

OncoNano Medicine raised a round of funding on March 28, 2018. Investors include Salem Partners.

OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple and effective identifier of disea…

Articles about OncoNano Medicine's Series A Round: